The Thai Red Cross Society

What The Thai Red Cross Society does

The Thai Red Cross Society is a Thailand-based non-profit humanitarian organization founded in 1893 and headquartered in Pathum Wan, operating with 501-1000 employees. It is part of the broader Red Cross movement and historically delivers charitable services for humanitarian causes across Thailand and Southeast Asia. The organization's financial model is not commercially driven; no funding rounds, revenue figures, or institutional investors are disclosed.

In March 2026, the Thai Red Cross Society entered a tri-party collaboration with Chulalongkorn University and Specialty Innovation Co., Ltd. to launch SALYWA, an artificial saliva product made from Thai herbal extracts (specifically ginger) using a Dual-Action concept designed to coat and moisturize the oral cavity. SALYWA is offered in two formulations: a 50ml gel at 300 THB and a 30ml spray at 275 THB. The product targets two end segments: head and neck cancer patients undergoing radiation therapy (a population in which 70-80% experience xerostomia per source data) and elderly individuals suffering from dry mouth. Distribution runs through Specialty Innovation Co., Ltd. as the licensed commercial partner, with a parallel charitable fund mechanism providing the product free of charge to underprivileged patients. The organization does not disclose marketing channels, certifications, management team details, or geographic expansion beyond its domestic Thai market.

Name

The Thai Red Cross Society

Legal name

The Thai Red Cross Society

Website

https://redcross.or.th

Company type

Private

Founded year

1893

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The Thai Red Cross Society is a Thai non-profit humanitarian organization that, in March 2026, partnered with Chulalongkorn University and Specialty Innovation Co., Ltd. to launch SALYWA, a Thai herbal-based artificial saliva product for cancer patients and elderly individuals with dry mouth.

Ownership category

akta.pro rank

Product category

Humanitarian Healthcare Services

NAICS

Health and Personal Care Retailers (456), Voluntary Health Organizations (813212)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Tongue Cleaners & Breath Fresheners (CRABAFAI)

akta.pro secondary industries

WASH & Public Health (Water, Sanitation, Hygiene) (BPADAIAG), Hand Sanitizers & Antibacterial Personal Care (CRADANAI), Botanical/Herbal & Adaptogen Functional Beverage Production (AFAFAFAF)

Keywords

• Humanitarian services
• Non-profit healthcare
• Oral care products
• Herbal therapeutics
• Charitable healthcare

Headquarters

HQ city

Pathum Wan

HQ country

Thailand

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Others

Revenue model

1. SALYWA Product Sales: Sales of artificial saliva products (gel and spray) to patients. The collaboration also includes providing the product free of charge to underprivileged patients through a charitable fund.

Pricing tiers

Distribution channels1 record

Core offering

The Thai Red Cross Society is a humanitarian non-profit organization operating in Thailand. It coordinates charitable healthcare initiatives and, through a collaboration with Chulalongkorn University and Specialty Innovation Co., Ltd., brings to market SALYWA, an artificial saliva product made from Thai herbal extracts (ginger) using a Dual-Action concept to coat and moisturize the oral cavity for cancer patients undergoing radiation therapy and elderly individuals with dry mouth. The product is also distributed free of charge to underprivileged patients via a charitable fund.

Product overview

The Thai Red Cross Society, in partnership with Chulalongkorn University and Specialty Innovation Co., Ltd., offers SALYWA, an artificial saliva product. SALYWA is a Thai herbal-based medical product designed to relieve dry mouth symptoms, available in two formulations: a gel (300 THB/50ml) and a spray (275 THB/30ml). The product serves cancer patients undergoing radiation therapy and elderly individuals, with charitable distribution to underprivileged patients through the Society's fund.

Differentiator

Problem solved

Functional benefit

Brands

• SALYWA: Artificial saliva product made from Thai herbal extracts (ginger extract) designed to relieve dry mouth in cancer patients undergoing radiation therapy and elderly individuals. Available as gel (300 THB/50ml) and spray (275 THB/30ml).

Products and services

• SALYWA Artificial Saliva Gel An artificial saliva gel made from Thai herbal extracts (ginger) using a Dual-Action concept to coat and moisturize the oral cavity, providing relief from dry mouth (xerostomia) for cancer patients undergoing radiation therapy and elderly individuals. Packaged in a 50ml bottle.
• SALYWA Artificial Saliva Spray An artificial saliva spray made from Thai herbal extracts (ginger) using a Dual-Action concept to coat and moisturize the oral cavity, providing relief from dry mouth for cancer patients undergoing radiation therapy and elderly individuals. Packaged in a 30ml bottle.

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• Chulalongkorn UniversitycoreStrategic or Co-development Partner · 26 March 2026Chulalongkorn University partnered with Thai Red Cross Society and Specialty Innovation Co., Ltd. to develop and launch the SALYWA artificial saliva product. The collaboration aims to bring Thai research into practical use for patients suffering from dry mouth conditions.
• Specialty Innovation Co., Ltd.coreOEM/ Whitelabel/ Licensing Partner · 26 March 2026Specialty Innovation Co., Ltd. is the licensing partner for SALYWA artificial saliva product, collaborating with Chulalongkorn University and Thai Red Cross Society to bring the Thai herbal-based dry mouth relief product to market.

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• Biotène (Haleon): Biotène is the global market-leading artificial saliva and dry-mouth relief brand, owned by Haleon. It directly competes with SALYWA in the same product category — oral moisturizing products for xerostomia patients — with deep distribution across pharmacies, oncology centers, and retail in Thailand and worldwide.
• Xerostom (Bio-Xin): Xerostom is a dry-mouth relief product line addressing the same xerostomia condition as SALYWA, sold in pharmacy and dental channels. It is a direct competitor in artificial saliva and oral moisturizing formulations for cancer patients and elderly users.
• Moi-Stir: Moi-Stir is a long-standing artificial saliva spray product for dry-mouth relief, directly competing with SALYWA Spray in the same oncology and elderly care use cases. It represents a comparable formulation approach and pricing tier.
• GC Dry Mouth Gel (GC Corporation): GC Corporation produces a Dry Mouth Gel distributed through dental and pharmacy channels as an oral moisturizing product. It competes directly with SALYWA Gel for the same xerostomia patient population, particularly through dental professional recommendations.
• Oasis Mouth Spray (Ultrapharm): Oasis Mouth Spray is a competing artificial saliva spray product targeting the same dry-mouth relief use case as SALYWA. It is sold through pharmacy and hospital channels and represents a comparable single-format competitor in the artificial saliva category.

Broad incumbents

• Haleon: Haleon is a global consumer healthcare company owning Biotène and a broad oral care portfolio (Sensodyne, Aquafresh). It is a broad incumbent competing with SALYWA through multiple product lines, distribution channels, and significantly larger R&D and marketing budgets.
• Colgate-Palmolive: Colgate-Palmolive is a global oral care giant with adjacent dry-mouth and elderly oral care offerings, including Moi-Stir. It is a broad incumbent in oral care with vastly greater distribution, brand recognition, and clinical evidence generation capacity than SALYWA.
• International Committee of the Red Cross (ICRC): ICRC is the founding body of the international Red Cross movement to which Thai Red Cross Society belongs. It is a broad incumbent comparable as a humanitarian non-profit organization, though focused on conflict zones rather than product commercialization.

Regional players

• Thai Government Pharmaceutical Organization (GPO): GPO is Thailand's state pharmaceutical manufacturer producing a broad range of medicines and health products domestically. It is a regional player in the same Thai healthcare ecosystem as Thai Red Cross Society, often partnering with government hospitals and serving overlapping patient populations.

Others

• Specialty Innovation Co., Ltd. Specialty Innovation is the licensing and distribution partner for SALYWA, collaborating with Thai Red Cross Society and Chulalongkorn University. It is an ecosystem participant rather than a direct competitor, but is critical context as the commercialization vehicle for the product line.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/thairedcross
• LinkedInlinkedin.com/company/the-thai-red-cross-society

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Thai Red Cross Society